Aetion, a startup focusing on real-world evidence in healthcare, announced a five-year research collaboration with the FDA's Oncology Center of Excellence (OCE).
The OCE will use Aetion's Evidence Platform to find and analyze sources of real-world data that could be used for research on cancer prevention, clinical care, diagnostics and treatment.
The collaboration will assess real-world...
Aetion, a tech startup focused on real-world evidence in healthcare, announced plans to buy synthetic real-world data company Replica Analytics for an undisclosed sum.
This news comes less than a year after Aetion announced a $110 million Series C funding round led by Warburg Pincus.
"Replica is a pioneer in [synthetic data generation software], and this means that they are creating privacy-...
Aetion, a tech startup focused on real-world evidence in healthcare, landed $110 million in Series C funding. Warburg Pincus led the round, with participation from B Capital and Foresite Capital.
This comes less than a year after the company closed its $19 million Series B extension round. Today the company boasts of raising a total of $212 million.
WHAT IT DOES
The company works with biopharma...
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company.
WHAT IT DOES
Founded in 2013, the company's platform provides insights from RWE to decision-makers...
Real-world evidence platforms Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety and effectiveness data. The Real-Time Trend Reporting and Interactive...
Digital diabetes management company Glooko has announced the appointments of a new CCO and COO.
The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier, he will be in charge of key strategic partners and revenue generation for Glooko.
“As the leader in diabetes data management, Glooko is integrated with more diabetes and health devices than any other platform in the...
Dr. John Halamka, a longtime CIO, executive director and professor tied to Harvard-affiliated Beth Israel Deaconness Medical Center, will be joining the Mayo Clinic on January 1 as the new president of its Mayo Clinic Platform — a digital health project that will deploy “artificial intelligence, the internet of things and an ecosystem of partners,” he wrote in a blog post announcing the move....
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
New York City-based Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $27 million in a funding round supported by new backers Sanofi, UCB, McKesson Ventures and Horizon Health Services, according to a release. Prior investors including NEA, Flare Capital and Lakestar also participated.
An add-on to prior funding from last year, today’s...
New York-based healthcare technology company, Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $11.2 million in Series A funding. Flare Capital Partners, a VC firm focused on early stage health technology and services, led the round, and Lakestar also contributed.
Aetion’s Evidence Platform, which the company launched in 2015, allows...
